Elinzanetant for treating vasomotor symptoms caused by adjuvant endocrine treatment to prevent or treat hormone-receptor positive breast cancer [ID6544]

  • Awaiting development
  • GID-TA11720
  • Expected publication date: TBC

36123-Elinzanetant-for-Vasomotor-Symptoms-V1.0-DEC2024-NON-CONF.pdf